Survival Analysis of Oral Cancer Patients
NCT04967638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74
Last updated 2021-07-19
Summary
This study aims to assess the survival rate of oral squamous cell carcinoma (OSCC) patients following immediate mandibular reconstruction with vascularized fibula flap (VFF) and to identify risk factors influencing the overall survival rate and postoperative outcomes.
Conditions
Interventions
- PROCEDURE
-
tumor resection and mandible reconstruction
The patients who underwent primary ablative tumor resection with segmental mandibulectomy and immediate VFF reconstruction were retrieved from the database
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2020-09-01
- Completion
- 2020-12-01
Countries
- Belgium
Study Locations
More Related Trials
-
Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells
NCT01484769 ·Status: WITHDRAWN
-
A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
NCT02743832 ·Status: RECRUITING ·Phase: NA
-
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
NCT04086849 ·Status: COMPLETED
-
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
NCT02015650 ·Status: TERMINATED ·Phase: PHASE4
-
Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
NCT01919567 ·Status: UNKNOWN
-
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420 ·Status: RECRUITING ·Phase: NA
-
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
NCT00357617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
NCT02990936 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
NCT01606566 ·Status: TERMINATED ·Phase: PHASE2
-
This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck
NCT07066878 ·Status: NOT_YET_RECRUITING
-
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
NCT00868491 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
NCT00201383 ·Status: COMPLETED ·Phase: PHASE3
-
Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+
NCT03121313 ·Status: UNKNOWN ·Phase: PHASE2
-
Survival With Patients Treated With Salivary Gland Cancer
NCT05390294 ·Status: COMPLETED
-
Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery
NCT00714649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.
NCT04445064 ·Status: TERMINATED ·Phase: PHASE2
-
Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
NCT00002747 ·Status: UNKNOWN ·Phase: PHASE3
-
A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
NCT06138483 ·Status: RECRUITING
-
Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer
NCT00768664 ·Status: COMPLETED ·Phase: PHASE2
-
Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer
NCT02572778 ·Status: RECRUITING
-
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
NCT07044635 ·Status: RECRUITING ·Phase: PHASE2
-
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 ·Status: RECRUITING
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614 ·Status: RECRUITING ·Phase: PHASE2
-
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
NCT00933387 ·Status: COMPLETED ·Phase: PHASE2